ImmunityBio, Inc.

IBRX · Healthcare

$7.87

Market cap: 8.34B USDDividend yield: —
AdvanceIs it a good moment to buy ImmunityBio, Inc.? Ask Copenvest AIGet an Advance AI take on timing, risk, and what tracked investors are doing.Ask Copenvest AI

Loading chart…

News

Latest headlines for this stock

ZacksSep 3, 2026, 3:30 PM

Why Is ImmunityBio (IBRX) Up 9.7% Since Last Earnings Report?

StocktwitsSep 1, 2026, 6:09 AM

SLS, IBRX Stocks Post August Gains: Eli Lilly’s Latest $2.9B Deal Has Retail Traders Bracing For An ‘M&A Rampage’